COMPAGNIE CHARGEURS INVEST (CRI.PA) Fundamental Analysis & Valuation

EPA:CRI • FR0000130692

9.62 EUR
-0.18 (-1.84%)
Last: Mar 13, 2026, 12:48 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This CRI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

CRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 17 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of CRI have multiple concerns. CRI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. CRI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year CRI was profitable.
  • In the past year CRI had a positive cash flow from operations.
  • Of the past 5 years CRI 4 years were profitable.
  • In multiple years CRI reported negative operating cash flow during the last 5 years.
CRI.PA Yearly Net Income VS EBIT VS OCF VS FCFCRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.28%, CRI is doing worse than 70.59% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 1.03%, CRI is doing worse than 70.59% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 5.14%, CRI is in line with its industry, outperforming 58.82% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CRI is below the industry average of 6.86%.
  • The last Return On Invested Capital (5.14%) for CRI is above the 3 year average (4.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.28%
ROE 1.03%
ROIC 5.14%
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
CRI.PA Yearly ROA, ROE, ROICCRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.37%, CRI is doing worse than 70.59% of the companies in the same industry.
  • CRI's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 6.41%, CRI is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of CRI has remained more or less at the same level.
  • The Gross Margin of CRI (28.51%) is worse than 76.47% of its industry peers.
  • CRI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.41%
PM (TTM) 0.37%
GM 28.51%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
CRI.PA Yearly Profit, Operating, Gross MarginsCRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CRI.PA Health Analysis

2.1 Basic Checks

  • CRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CRI has more shares outstanding than it did 1 year ago.
  • CRI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CRI has an improved debt to assets ratio.
CRI.PA Yearly Shares OutstandingCRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CRI.PA Yearly Total Debt VS Total AssetsCRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • CRI has an Altman-Z score of 1.23. This is a bad value and indicates that CRI is not financially healthy and even has some risk of bankruptcy.
  • CRI has a Altman-Z score of 1.23. This is in the lower half of the industry: CRI underperforms 64.71% of its industry peers.
  • The Debt to FCF ratio of CRI is 124.09, which is on the high side as it means it would take CRI, 124.09 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CRI (124.09) is worse than 64.71% of its industry peers.
  • A Debt/Equity ratio of 1.38 is on the high side and indicates that CRI has dependencies on debt financing.
  • CRI's Debt to Equity ratio of 1.38 is in line compared to the rest of the industry. CRI outperforms 41.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 124.09
Altman-Z 1.23
ROIC/WACC0.79
WACC6.49%
CRI.PA Yearly LT Debt VS Equity VS FCFCRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.30 indicates that CRI should not have too much problems paying its short term obligations.
  • CRI has a worse Current ratio (1.30) than 88.24% of its industry peers.
  • CRI has a Quick Ratio of 1.30. This is a bad value and indicates that CRI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.86, CRI is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.86
CRI.PA Yearly Current Assets VS Current LiabilitesCRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CRI.PA Growth Analysis

3.1 Past

  • CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 150.24%, which is quite impressive.
  • CRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.59% yearly.
  • The Revenue has been growing slightly by 6.67% in the past year.
  • CRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.10% yearly.
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%

3.2 Future

  • Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 33.91% on average per year.
  • The Revenue is expected to grow by 3.28% on average over the next years.
EPS Next Y-30.25%
EPS Next 2Y34.84%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue Next Year-1.02%
Revenue Next 2Y2.35%
Revenue Next 3Y3.28%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRI.PA Yearly Revenue VS EstimatesCRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
CRI.PA Yearly EPS VS EstimatesCRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. CRI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 74.00, the valuation of CRI can be described as expensive.
  • Based on the Price/Earnings ratio, CRI is valued a bit more expensive than the industry average as 70.59% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 25.71, CRI is valued quite expensively.
  • With a Price/Forward Earnings ratio of 11.98, the valuation of CRI can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, CRI is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
  • CRI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 74
Fwd PE 11.98
CRI.PA Price Earnings VS Forward Price EarningsCRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CRI is valued a bit cheaper than 76.47% of the companies in the same industry.
  • 64.71% of the companies in the same industry are cheaper than CRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 70.42
EV/EBITDA 7.21
CRI.PA Per share dataCRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • CRI's earnings are expected to grow with 33.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.84%
EPS Next 3Y33.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. CRI.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.30%, CRI has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.99, CRI is paying slightly less dividend.
  • Compared to the average S&P500 Dividend Yield of 1.82, CRI is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRI.PA Yearly Dividends per shareCRI.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

  • 118.52% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y34.84%
EPS Next 3Y33.91%
CRI.PA Yearly Income VS Free CF VS DividendCRI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M
CRI.PA Dividend Payout.CRI.PA Dividend Payout, showing the Payout Ratio.CRI.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CRI.PA Fundamentals: All Metrics, Ratios and Statistics

COMPAGNIE CHARGEURS INVEST

EPA:CRI (3/13/2026, 12:48:35 PM)

9.62

-0.18 (-1.84%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)11-05
Earnings (Next)03-19
Inst Owners4.62%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap239.44M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts74.29
Price Target12.41 (29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.39%
PT rev (3m)7.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)15.09%
EPS NY rev (3m)-35.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.33%
Revenue NY rev (3m)-3.33%
Valuation
Industry RankSector Rank
PE 74
Fwd PE 11.98
P/S 0.33
P/FCF 70.42
P/OCF 10.06
P/B 0.92
P/tB N/A
EV/EBITDA 7.21
EPS(TTM)0.13
EY1.35%
EPS(NY)0.8
Fwd EY8.35%
FCF(TTM)0.14
FCFY1.42%
OCF(TTM)0.96
OCFY9.94%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.54
Profitability
Industry RankSector Rank
ROA 0.28%
ROE 1.03%
ROCE 7.02%
ROIC 5.14%
ROICexc 6.13%
ROICexgc 13.12%
OM 6.41%
PM (TTM) 0.37%
GM 28.51%
FCFM 0.47%
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 124.09
Debt/EBITDA 4.67
Cap/Depr 66.89%
Cap/Sales 2.8%
Interest Coverage 250
Cash Conversion 30.87%
Profit Quality 125.93%
Current Ratio 1.3
Quick Ratio 0.86
Altman-Z 1.23
F-Score7
WACC6.49%
ROIC/WACC0.79
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y-30.25%
EPS Next 2Y34.84%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year-1.02%
Revenue Next 2Y2.35%
Revenue Next 3Y3.28%
Revenue Next 5YN/A
EBIT growth 1Y57.43%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year102.09%
EBIT Next 3Y37.85%
EBIT Next 5YN/A
FCF growth 1Y109.66%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y244.24%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%

COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ

What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.


What is the valuation status of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Overvalued.


What is the profitability of CRI stock?

COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for CRI stock?

The Price/Earnings (PE) ratio for COMPAGNIE CHARGEURS INVEST (CRI.PA) is 74 and the Price/Book (PB) ratio is 0.92.


How financially healthy is COMPAGNIE CHARGEURS INVEST?

The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.